• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 HYPERFORM; CATHETER, INTRAVASCULAR OCCLUDING, TEMPORARY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 HYPERFORM; CATHETER, INTRAVASCULAR OCCLUDING, TEMPORARY Back to Search Results
Model Number 104-4770
Device Problem Burst Container or Vessel (1074)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/17/2020
Event Type  malfunction  
Manufacturer Narrative
The hyperform balloon has not been returned for evaluation; therefore, product analysis cannot be performed.The device was not returned; therefore, the reported event could not be confirmed.The cause of the event cannot be conclusively determined from the provided information.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received a report that while inflating the air for a test, balloon was exploded.There were not any patient symptoms or complications associated with this event.Device was not used in the procedure.No patient injury was reported.
 
Manufacturer Narrative
H3: the hyperform occlusion balloon catheter and guidewire (model: 104-4770 lot: a809888) were returned for analysis.The guidewire was found protruding from within the catheter hub for ~119.0cm.Upon visual inspection, no damages were found with the hyperform hub, body or distal tip.The guidewire was removed from within the catheter lumen with slight resistance.Upon visual inspection, what appears to be dried contrast was found on the guidewire proximal solder region.No issues or irregularities were found with the guidewire distal solder region.The guidewire distal tip was found to be bent.The bend is consistent with shaping; however, it was not known if the guidewire tip was shaped during use.The guidewire distal tip od (outer diameter) was measured to be 0.0099¿ which is within specification (specification: 0.0103¿ max).An attempt was made to flush the hyperform occlusion balloon catheter but was found occluded with what is likely dried contrast.In order to test the balloon for inflation, the catheter body was separated (cut) a nd a mandrel was inserted into the distal tip.An attempt was made to inflate the balloon; however, the balloon could not maintain inflation as it was found to be leaking distal to the distal marker band at the tip.Upon microscopic examination, a defect (tear) in the balloon chronoprene tubing was found at the location of the leak.No balloon ¿ruptures¿ were found.No other anomalies were observed.There was an indication that the event could be related to a potential manufacturing issue; therefore, a device history record review will be performed.Based on the device analysis and reported information, the customer¿s report of ¿rupture¿ could not be confirmed as the balloon was not found to be ruptured.However, the device evaluation showed the balloon could not maintain inflation due to the defect (tear) in the chronoprene tubing.It is likely the damage to the balloon contributed to the event.Over-inflation of the balloon can cause the balloon to become damaged.However, the root cause for the damage could not be determined.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information received from a healthcare provider (hcp), via a manufacturing representative (rep), indicated the guidewire was discarded.The guidewire tip advanced to the very distal end of the catheter tip during inflation.The xpedion10 wire was used with the balloon for the inflation test.The procedure type was a bto.A competitor's product was used to complete the procedure and the distributor currently had the device for return.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HYPERFORM
Type of Device
CATHETER, INTRAVASCULAR OCCLUDING, TEMPORARY
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
MDR Report Key10180895
MDR Text Key196944591
Report Number2029214-2020-00577
Device Sequence Number1
Product Code MJN
Combination Product (y/n)N
PMA/PMN Number
K091458
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 09/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/20/2021
Device Model Number104-4770
Device Catalogue Number104-4770
Device Lot NumberA809888
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/02/2020
Initial Date Manufacturer Received 06/18/2020
Initial Date FDA Received06/22/2020
Supplement Dates Manufacturer Received06/24/2020
09/02/2020
Supplement Dates FDA Received07/05/2020
09/24/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age55 YR
Patient Weight75
-
-